Abstract:The Organic Cation Transporter Novel 1 (OCTN1), also known as SLC22A4, is widely expressed in various human tissues, and involved in numerous physiological and pathological processes remains. It facilitates the transport of organic cations, zwitterions, with selectivity for positively charged solutes. Ergothioneine, an antioxidant compound, and acetylcholine (Ach) are among its substrates. Given the lack of experimentally solved structures of this protein, this study aimed at generating a reliable 3D model of OCTN1 to shed light on its substrate-binding preferences and the role of sodium in substrate recognition and transport. A chimeric model was built by grafting the large extracellular loop 1 (EL1) from an AlphaFold-generated model onto a homology model. Molecular dynamics simulations revealed domain-specific mobility, with EL1 exhibiting the highest impact on overall stability. Molecular docking simulations identified cytarabine and verapamil as highest affinity ligands, consistent with their known inhibitory effects on OCTN1. Furthermore, MM/GBSA analysis allowed the categorization of substrates into weak, good, and strong binders, with molecular weight strongly correlating with binding affinity to the recognition site. Key recognition residues, including Tyr211, Glu381, and Arg469, were identified through interaction analysis. Ach demonstrated a low interaction energy, supporting the hypothesis of its one-directional transport towards to outside of the membrane. Regarding the role of sodium, our model suggested the involvement of Glu381 in sodium binding. Molecular dynamics simulations of systems at increasing levels of Na+ concentrations revealed increased sodium occupancy around Glu381, supporting experimental data associating Na+ concentration to molecule transport. In conclusion, this study provides valuable insights into the 3D structure of OCTN1, its substrate-binding preferences, and the role of sodium in the recognition. These findings contribute to the understanding of OCTN1 involvement in various physiological and pathological processes and may have implications for drug development and disease management.

In silico structural studies on the vesicular neutral amino acid transporter NTT4 (SLC6A17)

Molecular basis of inhibition of the amino acid transporter B AT1 (SLC6A19)

Glutamine Transport via Neurotransmitter Transporter 4 (NTT4, SLC6A17) Maintains Presynaptic Glutamate Supply at Excitatory Synapses in the Central Nervous System

Molecular basis of inhibition of the amino acid transporter B0AT1 (SLC6A19)

Structure-activity relationship of amino acid analogs to probe the binding pocket of sodium-coupled neutral amino acid transporter SNAT2

Neurotransmitter recognition by human vesicular monoamine transporter 2

Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy

Synthesis and Structure-Activity Relationships for Glutamate Transporter Allosteric Modulators

Atomistic description of the OCTN1 recognition mechanism via in silico methods

Structural basis of the obligatory exchange mode of human neutral amino acid transporter ASCT2

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2

Diversity of function and mechanism in a family of organic anion transporters

Successful prediction of substrate-binding pocket in SLC17 transporter sialin

Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1

Vesicular neurotransmitter transporters: mechanistic aspects

Exploring the Structural and Functional Effects of Nonsynonymous SNPs in the Human Serotonin Transporter Gene Through In Silico Approaches

Structural basis of substrate transport and drug recognition by the human thiamine transporter SLC19A3

Reanalysis of Structure/function Correlations in the Region of Transmembrane Segments 4 and 5 of the Rabbit Sodium/glucose Cotransporter.

Common structural features in some of the sequentially distant neurotransmitter transporters N-termini

The Human OCTN Sub-Family: Gene and Protein Structure, Expression, and Regulation

In silico characterization of residues essential for substrate binding of human cystine transporter, xCT